Alumis and Kaken Pharma announce collaboration worth $140 M for dermatology treatment in Japan

Alumis Inc., a US-based clinical-stage biopharmaceutical company and Japan's Kaken Pharmaceutical Co. have entered into ...

March 27, 2025 | Thursday | News
US-based Alamar Biosciences expands commercial support in Asia Pacific region

Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has an...

March 20, 2025 | Thursday | News
Japan's Taiho Pharma buys ADC firm Araris Biotech for $740 M

Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...

March 20, 2025 | Thursday | News
Japan's GHIT invests $11.4 M for treatment of neglected tropical diseases

Japan's Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.7 b...

March 19, 2025 | Wednesday | News
ABL Diagnostics partners with Riken Genesis to expand microbiology genotyping in Japan

ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, has announced an exclusive distribution agreement wi...

March 18, 2025 | Tuesday | News
Japan's Murata announces production of world's first metal cell fractionation filter

Japan-based Murata Manufacturing Co. has successfully commercialised and mass produced "CELLNETTA," the world’s fi...

March 17, 2025 | Monday | News
CII partners with SMRJ to host business meetings for medtech companies in India and Japan

Confederation of Indian Industry (CII) is partnering with Organization for Small & Medium Enterprises and Regio...

March 14, 2025 | Friday | News
ENCell signs MoU with Cell Resources Corp to pave way for market entry in Japan

ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...

March 14, 2025 | Friday | News
Daiichi Sankyo and Nosis Biosciences partner to advance RNA medicines

US-based Nosis Biosciences, an AI-driven biotechnology company specialising in RNA therapeutics for challenging cell typ...

March 13, 2025 | Thursday | News
Taiwan's Amaran Biotech signs MoU with Nippon to expand CDMO business

Amaran Biotechnology Inc., a subsidiary of OBI Pharma specialising in Contract Development and Manufacturing Organizatio...

March 12, 2025 | Wednesday | News
Japan grants Orphan Drug Designation to Lundbeck's potential treatment for Multiple System Atrophy

The Ministry of Health, Labour, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundb...

March 11, 2025 | Tuesday | News
CEPI funds Nagasaki University’s ‘Nanoball’ technology to help defeat Disease X

A new ‘nanoball’ vaccine platform developed by experts in Japan will be tested as part of new research, supp...

March 10, 2025 | Monday | News
Shimadzu announces launch of two models of Scanning Electron Microscope SUPERSCAN SS-4000

Shimadzu Corporation has launched two models of the scanning electron microscope “SUPERSCAN SS-4000” within ...

March 10, 2025 | Monday | News
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...

March 7, 2025 | Friday | News
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...

March 6, 2025 | Thursday | News
Olympus to launch single-use hemostasis clip in US, with plans for global expansion

Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...

March 5, 2025 | Wednesday | News
Japan's Shionogi inks agreement with Osaka Metropolitan University to establish model for city resilient to infectious diseases

Japan-based Shionogi & Co. has announced the conclusion of a comprehensive collaboration agreement with Osaka Metrop...

March 4, 2025 | Tuesday | News
“Personalised medicine is now a reality, not just an aspiration”

Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...

March 1, 2025 | Saturday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls